Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Maxcyte (MXCT) Shares Outstanding (Diluted Average) (2020 - 2025)

Historic Shares Outstanding (Diluted Average) for Maxcyte (MXCT) over the last 6 years, with Q3 2025 value amounting to $106.6 million.

  • Maxcyte's Shares Outstanding (Diluted Average) rose 143.04% to $106.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $106.6 million, marking a year-over-year increase of 143.04%. This contributed to the annual value of $104.8 million for FY2024, which is 153.07% up from last year.
  • Per Maxcyte's latest filing, its Shares Outstanding (Diluted Average) stood at $106.6 million for Q3 2025, which was up 143.04% from $106.4 million recorded in Q2 2025.
  • In the past 5 years, Maxcyte's Shares Outstanding (Diluted Average) registered a high of $106.6 million during Q3 2025, and its lowest value of $84.7 million during Q2 2021.
  • Its 5-year average for Shares Outstanding (Diluted Average) is $101.1 million, with a median of $103.2 million in 2023.
  • As far as peak fluctuations go, Maxcyte's Shares Outstanding (Diluted Average) skyrocketed by 3045.33% in 2021, and later surged by 120.93% in 2024.
  • Over the past 5 years, Maxcyte's Shares Outstanding (Diluted Average) (Quarter) stood at $90.6 million in 2021, then rose by 12.23% to $101.7 million in 2022, then rose by 1.54% to $103.3 million in 2023, then rose by 1.53% to $104.8 million in 2024, then increased by 1.68% to $106.6 million in 2025.
  • Its last three reported values are $106.6 million in Q3 2025, $106.4 million for Q2 2025, and $106.0 million during Q1 2025.